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Bronchial asthma is a pathological condition characterised by
chronic allergic inﬂammation of the airway.1 In recent years, it
has been suggested that there is a close relationship between func-
tional disturbances of airway epithelial cells and the development
and exacerbation of asthma.2 The airway is open to the external
environment and serves as ﬁrst line defence of the body against
invading environmental factors.3 While immunity is a self-
defence system based on discrimination between self and non-
self, the tight junctional barrier, which limits the entry of foreign
antigens, can be referred to as the selfenon-self boundary. Environ-
mental factors, such as allergens, viruses and air pollutants cause
repeated airway inﬂammation and direct epithelial injuries, which
lead to disrupted barrier functions of the airway epithelium and
excessive responsiveness to foreign substances. The E-cadherin-
based cell adhesion apparatus of airway epithelial cells is important
for the stabilisation of immune cells.4 For example, house dust-
induced damage to adherence junctions of the airway epithelium
has been reported to promote TSLP production in airway epithelial
cells.5 In addition, E-cadherin and tight junction proteins are
expressed in CD103-positive dendritic cells and are present be-
tween epithelial cells by homo binding to E-cadherin and tight
junction proteins of epithelial cells.6 These dendritic cells serve
an immune surveillance function in a normal state; however,
once epithelial injury is caused by inﬂammation, they undergo dif-
ferentiation and migration and induce an immune response. The
physical barrier function of the airway epithelium thus serves an
immunoregulatory function and is believed to play a critical role
in the development and progression of allergic inﬂammation.
Infection with RNA viruses, such as rhinovirus and respiratory
syncytial virus, is a major cause of the exacerbation of asthma. At
the time of RNA virus infection, double-stranded RNA (dsRNA) is
inevitably produced during virus replication within host cells.
dsRNA released outside cells is taken up by cells, recognised by
Toll-like receptor 3 (TLR3) on endosomes, which induces the pro-
duction of cytokines and chemokines. TLR3-mediated response of
airway epithelial cells to dsRNA is an important element in the
pathogenesis of allergic airway inﬂammation.1,7
In this study, we investigated the mechanism by which dsRNA
destroys the airway epithelial cell barrier. Transformed human
bronchial epithelial (16HBE140, abbreviated as 16HBE) cells
were kindly donated by Dr. Dieter C. Gruenert (Gene Therapy Cen-
ter, Cardiovascular Research Institute, Department of LaboratoryPeer review under responsibility of Japanese Society of Allergology.
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licenses/by-nc-nd/4.0/).Medicine, University of California San Francisco, USA.). 16HBE cells
were cultured in a Transwell chamber (Corning Costar, Lowell,
MA, USA) for 24 h and for an additional 2 days in the presence
of 1 or 10 mg/ml of polyinosinicepolycytidylic acid (poly-IC) (Sig-
maeAldrich Corporation, St. Louis, MO, USA), a synthetic dsRNA.
The epithelial barrier function was assessed by measuring the
transepithelial electrical resistance (TER) with millicellTER (Milli-
pore, Billerica, MA, USA). Permeability was measured using
4 kDa ﬂuorescein isothiocyanateedextran (FITCedextran), and
apparent permeability coefﬁcients were calculated (Papp in cm/
s).8,9
Poly-IC treatment of 16HBE cells decreased TER and increased
FITCedextran permeability (Fig. 1). It did not affect the proliferation
or viability of 16HBE cells (data not shown). Transfection with
TLR3-speciﬁc siRNA suppressed the poly-IC-induced decrease and
increase in TER and FITCedextran permeability, respectively,
revealing the critical role of TLR3 activation in the epithelial barrier
disruption (Fig. 1A). It has been reported that the intracellular TLR3
signal transduction involves pathways mediated by MyD88 and
TRIF as adaptor molecules, through which transcription factors,
such as NF-kB and IRF, are activated and cytokine production is
induced. Next, we investigated the roles of MyD88 and TRIF in
intracellular signalling pathways that are triggered by TLR3 activa-
tion and lead to the epithelial barrier disruption. The transfection
with MyD88-speciﬁc siRNA signiﬁcantly suppressed the TER in
the condition with or without poly-IC treatment. The poly-IC-
induced decrease in TER was not inhibited by transfection with
TRIF-speciﬁc siRNA (Fig. 1B, C). These results suggest that constitu-
tive expression and activation of Myd88would be important for the
stability of barrier function, and TRIF would play a crucial role on
the TLR3-mediated barrier disruption.
Next, we used RT-PCR to analyse poly-IC-induced changes in
mRNA expression of these molecules to determine the effects of
TLR3 activation by dsRNA on the expression of tight junction
and adherence junction molecules. After poly-IC treatment,
with the exception of claudin-6 and -7, all claudin members
that have been conﬁrmed to be expressed in bronchial epithelial
cells (claudin-1, -3, -4, -5, -6, -7, -9, -11, -16, -18 and -19) showed
signiﬁcant decrease in expression with a 50% decrease in
cluadin-9 and claudin-19 (Fig. 2). In contrast, the expression of
adherence junction protein E-cadherin and tight junction mole-
cules occludin and ZO-1, and -2 did not decrease (Fig. 2). These
results suggest that the epithelial barrier function was impaired
through decreased expression of multiple claudin members as a
consequence of the activation of the TLR3eTRIF-mediated signal-
ling pathway.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1. Roles of TLR3, MyD88 and TRIF in poly-IC-induced barrier impairment. (A, upper) 16HBE cells transfected with control siRNA (siCTR) or TLR3-speciﬁc siRNA (siTLR3) were
treated with poly-IC (1 or 10 mg/ml) and measured TER at 48 h after the poly-IC treatment. 16HBE cells transfected with siCTR or siTLR3 were measured TER at 48 h after the treat-
ment. %TER represents percentage in reference to the siCTR-transfected cells without poly-IC treatment. (A, bottom) siCTR- and siTLR3-transfected cells were treated with poly-IC (1
or 10 mg/ml) and subjected to the FITCedextran permeability assay at 48 h. The vertical axis represents apparent permeability coefﬁcients (Paap).8 (B) %TER of cells transfected with
MyD88-specifc siRNA (siMyD88) at 48 h after the treatment with 10 mg/ml poly-IC. (C) %TER of cells transfected with TRIF-speciﬁc siRNA (siTRIF) after the treatment. Asterisks
indicate a statistically signiﬁcant difference (P  0.05) compared to control.
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Fig. 2. Changes in expression levels of adherence junction and tight junction mole-
cules after poly-IC treatment. RT-PCR analysis of E-cadherin, Zo-1 and -2 and
claudin-1, -3, -4, -5, -6, -7, -9, -11, -16, -18 and -19 mRNA. Expression levels are shown
as ratios of post-48-h-poly-IC-treatment to pre-treatment values. Asterisks indicate a
statistically signiﬁcant difference (P  0.05) compared to control.
Letter to the Editor / Allergology International 65 (2016) S56eS58S58Based on previous studies, claudins can be divided into three
functionally distinct groups. Claudin-1, -3, -4, -5, -8, -11, -14, -16
and -19 function to seal paracellular permeability, whereas
claudin-2 and -10 enhance paracellular permeability. Claudin-7,
-12, -15 and -16 have been reported to have both functions.10 The
dsRNA-induced decrease in the expression of claudin-3, -5, -11,
-19 and other claudins in this study likely result in increased para-
cellular permeability. The mechanism by which TLR3eTRIF activa-
tion induced decreased expression of claudin members was not
determined in the present study and will require further studies
in the future.In conclusion, the progression of bronchial asthma, which is
closely related to RNA virus infection, has been suggested to be
mechanistically related not only to the production of cytokines
such as TSLP but also to the impaired barrier function of the epithe-
lium due to decreased expression of claudin members, both of
which are triggered by TLR3 activation by dsRNA.Acknowledgement
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